Physicians’ Tastes For Pricier Implants Not Always Improving Patient Results, Hospital Group Says
This article was originally published in The Gray Sheet
Executive Summary
UHC, an alliance of nonprofit academic centers, released a white paper finding that higher-priced physician preferences for orthopedic implants, coronary and peripheral stents and heart valves are increasing hospitals’ supply costs, but not necessarily improving patients’ outcomes.
You may also be interested in...
AdvaMed: Devices Not The Cause Of Health Care Inflation
The price of implantable devices declined between 2007 and 2011, according to an AdvaMed-sponsored study. Industry officials touted the finding at the trade group’s annual medtech conference in Washington, D.C.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.